Novo expands research collaboration with US universities
A collaboration between Novo Nordisk and Massachusetts Institute of Technology (MIT) resulted in robotic pill, SOMA. Now, the company is continuing, and expanding, the partnership.
by CHRISTIAN BUNDGAARD, translated by daniel pedersen
Novo Nordisk is continuing to explore alternative drug delivery technologies to conventional syringes and pen injectors.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
